Keep the feds out of drug pricing

  • USA Today | by: Peter J. Pitts |
  • 12/18/2016
Letter to the editor:

Allowing the federal government to negotiate drug prices, as suggested by Minnesota Sen. Amy Klobuchar’s column “Let’s work with Trump to reduce drug prices,” would result in prices going up and patient choice going down.

According to the Congressional Budget Office, allowing Uncle Sam to negotiate Medicare drug prices would have a “negligible effect” on Medicare drug spending. Its report from 2009, reiterated this view, explaining that such a reform would “have little, if any, effect on (drug) prices.”

 
Sign Up for Our Email Newsletter

RECENT NEWS

How Other Countries Freeload on U.S. Drug Research

How Other Countries Freeload on U.S. Drug Research

Letting Americans buy prescriptions from foreign retailers would impair the development of new cures....  Read more

Reduce drug prices by eliminating PBM rebates

Reduce drug prices by eliminating PBM rebates

Unless we end the rigged system of rebates, insurers, PBMs and drug companies will find themselves threatened with more g...  Read more

The Privacy Delusions Of Genetic Testing

The Privacy Delusions Of Genetic Testing

Genetic-testing companies cannot guarantee privacy. And many are actively selling user data to outside parties....  Read more

DRUGWONKS BLOG